Medication info
Rozetel Tablet 80/20/10 Milligrams

Rozetel Tablet 80/20/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202106686 · Approved 2021.09.29 · Insurance code 643606210

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This drug is for use only in adults. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of telmisartan orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, measure blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly, switching to this drug (a combination tablet containing the same amounts of each active ingredient) may be considered for convenience.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease

  • Essential hypertension
  • cardiovascular disease
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • end-organ damage
  • high-risk diabetes
  • myocardial infarction
  • primary hypercholesterolemia
  • familial combined dyslipidemia
  • non-familial dyslipidemia
View approved original text

This medication is used for patients who need to take telmisartan and rosuvastatin/ezetimibe together. Telmisartan treats essential hypertension and reduces the risk of myocardial infarction, stroke, and death from cardiovascular disease in high-risk cardiovascular disease patients. It is particularly effective in cardiovascular disease high-risk patients over 55 years of age who cannot use ACE inhibitors. Rosuvastatin/ezetimibe lowers cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while also increasing HDL, the good cholesterol. This medication is used as an adjunct to diet therapy to improve blood lipid levels. Therefore, this medication is used to manage both hypertension and dyslipidemia simultaneously to improve cardiovascular health.

How to take

Adult dose

This drug is for use only in adults. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of telmisartan orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, measure blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly, switching to this drug (a combination tablet containing the same amounts of each active ingredient) may be considered for convenience.

Precautions

This medication can cause severe harm to the fetus or newborn if taken during pregnancy, so it must be stopped immediately if pregnancy is confirmed. Muscle-related side effects can occur, albeit rarely, and if symptoms such as muscle pain or weakness appear, a doctor should be consulted immediately. It can affect liver function, so it should not be used or should be used with caution in patients with liver disease or who have abnormal liver enzyme levels. It is contraindicated in patients with severe renal impairment or certain liver diseases. As this medication lowers blood pressure, symptoms of hypotension may occur, and patients with insufficient blood volume should be especially cautious. Interactions may occur when taken with other medications, so patients should inform their doctor or pharmacist about any medications they are taking. Caution is advised while driving or operating machinery as dizziness or drowsiness can occur. Patients with allergies to the components of this medication or specific genetic issues such as lactose intolerance should not take it. Elderly patients, diabetic patients, and those with reduced kidney function should use this medication especially carefully, and regular blood tests and physical examinations are necessary. While taking this medication, side effects such as muscle pain, fatigue, indigestion, headache, and dizziness may occur, and if symptoms are severe or persistent, medical advice should be sought.

Side effects

Increased ALT, Increased AST, Increased Ɣ-GTP, Increased ALP, Abdominal pain, Oral ulcers, Vomiting, Chest pain, Palpitations, Dizziness, Dyspnea, Functional impairment of the Eustachian tube, Tympanic membrane perforation, Acute kidney injury, Hematuria, Herpes zoster, Pneumonia, Non-small cell lung cancer, Hair loss, Dysuria, Rhinitis, Discomfort in the oropharynx, Pulmonary disease, Unspecified intestinal disease, Benign gastrointestinal neoplasm, Hemorrhoids, Skeletal pain, Osteoporosis, Sensory loss, Movement disorders, Atherosclerosis, Frequent urination, Tinnitus, Hearing loss, Halitosis, Fatty liver, Chest pain, Facial swelling, Strange sensations, Drug intolerance, Irritable bowel syndrome, Esophagitis, Somnolence, Neurodegenerative disorders, Positional dizziness, Migraine, Diabetes, Impaired glucose tolerance, Depression, Bronchitis, Cystitis, Onychomycosis, Soft tissue infection, Hepatic steatosis, Liver dysfunction, Hepatotoxicity, Acute hepatitis, Toxic hepatitis, Increased gamma-glutamyl transferase, Increased blood cholesterol, Increased alkaline phosphatase, Irregular heartbeat, Osteoarthritis, Musculoskeletal stiffness, Musculoskeletal discomfort, Muscle weakness, Cold sweat, Dermatitis, Skin burning sensation, Skin disorders, Alopecia, Oropharyngeal pain, Nasal obstruction, Respiratory distress, Pelvic pain, Breast cyst, Eyelid drooping, Diabetic retinopathy, Ear discomfort, Renal dysfunction, Benign esophageal neoplasm, Upper respiratory tract infection, Urinary tract infection, Sepsis, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Abdominal pain, Diarrhea, Indigestion, Abdominal bloating, Abdominal discomfort, Dry mouth, Liver function abnormalities, Liver disorders, Increased sweating, Itching, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Urticaria, Myalgia, Low back pain, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute renal failure, Weakness, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Elevated serum creatine kinase, Decreased hemoglobin, Headache, Facial spasms, Sensory abnormalities, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Weakness, Edema, Decreased libido, Facial edema, Rash, Alopecia, Conjunctivitis, Tinnitus, Petechiae, Peripheral neuropathy, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms syndrome, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Urticaria, Hyperhidrosis, Itching, Epigastric pain, Vomiting, Gastritis, Constipation, Xerostomia, Epigastric discomfort, Belching, Gastrointestinal disorders, Gastroesophageal reflux disease, Tongue disorders, Palpitations, Congestive heart failure, Myocardial ischemia, Bronchitis, Sputum, Nasal discharge, Limb pain, Arthralgia, Diabetes, Hypoglycemia, Anemia, Splenomegaly, Conjunctival injection, Renal failure, Abnormal liver function tests, Increased blood pressure, Increased blood urea, Elevated CPK, Abnormal liver function tests, Shock, Loss of consciousness, Interstitial pneumonia, Rhabdomyolysis, Nausea, Insufficient effect, Arrhythmia, Angioedema, Angioedema, Angioedema, Angioedema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, and stored at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.